Silverfin false false 30/11/2025 01/12/2024 30/11/2025 Dr C Gilling-Smith 02/06/2005 Ms M Gilling-Ulph 05/07/2021 Mr S Gilling-Ulph 25/11/2025 Mr C Gilling-Ulph 25/11/2025 26 August 2026 The principal activity of the company during the financial year was general medical practice activities. 05470318 2025-11-30 05470318 bus:Director1 2025-11-30 05470318 bus:Director2 2025-11-30 05470318 bus:Director3 2025-11-30 05470318 bus:Director4 2025-11-30 05470318 2024-11-30 05470318 core:CurrentFinancialInstruments 2025-11-30 05470318 core:CurrentFinancialInstruments 2024-11-30 05470318 core:Non-currentFinancialInstruments 2025-11-30 05470318 core:Non-currentFinancialInstruments 2024-11-30 05470318 core:ShareCapital 2025-11-30 05470318 core:ShareCapital 2024-11-30 05470318 core:CapitalRedemptionReserve 2025-11-30 05470318 core:CapitalRedemptionReserve 2024-11-30 05470318 core:RetainedEarningsAccumulatedLosses 2025-11-30 05470318 core:RetainedEarningsAccumulatedLosses 2024-11-30 05470318 core:LandBuildings 2024-11-30 05470318 core:LeaseholdImprovements 2024-11-30 05470318 core:PlantMachinery 2024-11-30 05470318 core:Vehicles 2024-11-30 05470318 core:FurnitureFittings 2024-11-30 05470318 core:ComputerEquipment 2024-11-30 05470318 core:LandBuildings 2025-11-30 05470318 core:LeaseholdImprovements 2025-11-30 05470318 core:PlantMachinery 2025-11-30 05470318 core:Vehicles 2025-11-30 05470318 core:FurnitureFittings 2025-11-30 05470318 core:ComputerEquipment 2025-11-30 05470318 core:CurrentFinancialInstruments core:Secured 2025-11-30 05470318 core:Non-currentFinancialInstruments core:MoreThanFiveYears 2025-11-30 05470318 core:Non-currentFinancialInstruments core:MoreThanFiveYears 2024-11-30 05470318 bus:OrdinaryShareClass1 2025-11-30 05470318 bus:OrdinaryShareClass2 2025-11-30 05470318 bus:OrdinaryShareClass3 2025-11-30 05470318 bus:OrdinaryShareClass4 2025-11-30 05470318 core:WithinOneYear 2025-11-30 05470318 core:WithinOneYear 2024-11-30 05470318 core:BetweenOneFiveYears 2025-11-30 05470318 core:BetweenOneFiveYears 2024-11-30 05470318 2024-12-01 2025-11-30 05470318 bus:FilletedAccounts 2024-12-01 2025-11-30 05470318 bus:SmallEntities 2024-12-01 2025-11-30 05470318 bus:AuditExemptWithAccountantsReport 2024-12-01 2025-11-30 05470318 bus:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 05470318 bus:Director1 2024-12-01 2025-11-30 05470318 bus:Director2 2024-12-01 2025-11-30 05470318 bus:Director3 2024-12-01 2025-11-30 05470318 bus:Director4 2024-12-01 2025-11-30 05470318 core:LandBuildings core:TopRangeValue 2024-12-01 2025-11-30 05470318 core:LeaseholdImprovements core:TopRangeValue 2024-12-01 2025-11-30 05470318 core:PlantMachinery core:TopRangeValue 2024-12-01 2025-11-30 05470318 core:Vehicles core:TopRangeValue 2024-12-01 2025-11-30 05470318 core:FurnitureFittings core:TopRangeValue 2024-12-01 2025-11-30 05470318 core:ComputerEquipment core:TopRangeValue 2024-12-01 2025-11-30 05470318 2023-12-01 2024-11-30 05470318 core:LandBuildings 2024-12-01 2025-11-30 05470318 core:LeaseholdImprovements 2024-12-01 2025-11-30 05470318 core:PlantMachinery 2024-12-01 2025-11-30 05470318 core:Vehicles 2024-12-01 2025-11-30 05470318 core:FurnitureFittings 2024-12-01 2025-11-30 05470318 core:ComputerEquipment 2024-12-01 2025-11-30 05470318 bus:OrdinaryShareClass1 2024-12-01 2025-11-30 05470318 bus:OrdinaryShareClass1 2023-12-01 2024-11-30 05470318 bus:OrdinaryShareClass2 2024-12-01 2025-11-30 05470318 bus:OrdinaryShareClass2 2023-12-01 2024-11-30 05470318 bus:OrdinaryShareClass3 2024-12-01 2025-11-30 05470318 bus:OrdinaryShareClass3 2023-12-01 2024-11-30 05470318 bus:OrdinaryShareClass4 2024-12-01 2025-11-30 05470318 bus:OrdinaryShareClass4 2023-12-01 2024-11-30 05470318 bus:OrdinaryShareClass5 2024-12-01 2025-11-30 05470318 bus:OrdinaryShareClass5 2023-12-01 2024-11-30 iso4217:GBP xbrli:pure xbrli:shares

Company No: 05470318 (England and Wales)

AGORA GYNAECOLOGY AND FERTILITY CENTRE LTD

Unaudited Financial Statements
For the financial year ended 30 November 2025
Pages for filing with the registrar

AGORA GYNAECOLOGY AND FERTILITY CENTRE LTD

Unaudited Financial Statements

For the financial year ended 30 November 2025

Contents

AGORA GYNAECOLOGY AND FERTILITY CENTRE LTD

COMPANY INFORMATION

For the financial year ended 30 November 2025
AGORA GYNAECOLOGY AND FERTILITY CENTRE LTD

COMPANY INFORMATION (continued)

For the financial year ended 30 November 2025
Directors Dr C Gilling-Smith
Ms M Gilling-Ulph
Mr S Gilling-Ulph (Appointed 25 November 2025)
Mr C Gilling-Ulph (Appointed 25 November 2025)
Registered office 138 Dyke Road
Brighton
BN1 5PA
United Kingdom
Company number 05470318 (England and Wales)
Accountant Kreston Reeves LLP
Springfield House
Springfield Road
Horsham
West Sussex
RH12 2RG

ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS ON THE PREPARATION OF
THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF AGORA GYNAECOLOGY AND FERTILITY CENTRE LTD

For the financial year ended 30 November 2025

ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS ON THE PREPARATION OF
THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF AGORA GYNAECOLOGY AND FERTILITY CENTRE LTD (continued)

For the financial year ended 30 November 2025

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Agora Gynaecology And Fertility Centre Ltd for the financial year ended 30 November 2025 which comprise the Balance Sheet and the related notes 1 to 9 from the Company’s accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at www.icaew.com/regulation.

This report is made solely to the Board of Directors of Agora Gynaecology And Fertility Centre Ltd, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the financial statements of Agora Gynaecology And Fertility Centre Ltd and state those matters that we have agreed to state to the Board of Directors of Agora Gynaecology And Fertility Centre Ltd, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Agora Gynaecology And Fertility Centre Ltd and its Board of Directors as a body for our work or for this report.

It is your duty to ensure that Agora Gynaecology And Fertility Centre Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Agora Gynaecology And Fertility Centre Ltd. You consider that Agora Gynaecology And Fertility Centre Ltd is exempt from the statutory audit requirement for the financial year.

We have not been instructed to carry out an audit or a review of the financial statements of Agora Gynaecology And Fertility Centre Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

Kreston Reeves LLP

Springfield House
Springfield Road
Horsham
West Sussex
RH12 2RG

27 August 2026

AGORA GYNAECOLOGY AND FERTILITY CENTRE LTD

BALANCE SHEET

As at 30 November 2025
AGORA GYNAECOLOGY AND FERTILITY CENTRE LTD

BALANCE SHEET (continued)

As at 30 November 2025
Note 2025 2024
£ £
Fixed assets
Tangible assets 3 6,857,220 7,442,018
6,857,220 7,442,018
Current assets
Debtors 4 1,035,433 805,670
Cash at bank and in hand 275,065 371,419
1,310,498 1,177,089
Creditors: amounts falling due within one year 5 ( 1,678,141) ( 1,845,351)
Net current liabilities (367,643) (668,262)
Total assets less current liabilities 6,489,577 6,773,756
Creditors: amounts falling due after more than one year 6 ( 3,373,715) ( 3,589,341)
Provision for liabilities ( 374,020) ( 493,000)
Net assets 2,741,842 2,691,415
Capital and reserves
Called-up share capital 7 66,855 66,855
Capital redemption reserve 63,145 63,145
Profit and loss account 2,611,842 2,561,415
Total shareholders' funds 2,741,842 2,691,415

For the financial year ending 30 November 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Agora Gynaecology And Fertility Centre Ltd (registered number: 05470318) were approved and authorised for issue by the Board of Directors on 26 August 2026. They were signed on its behalf by:

Dr C Gilling-Smith
Director
AGORA GYNAECOLOGY AND FERTILITY CENTRE LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 30 November 2025
AGORA GYNAECOLOGY AND FERTILITY CENTRE LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 30 November 2025
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Agora Gynaecology And Fertility Centre Ltd (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is The Agora, 138 Dyke Road, Brighton, West Sussex, BN1 5PA, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £1.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Employee benefits

Defined contribution schemes
The Company operates a defined contribution scheme. The amount charged to the Statement of Income and Retained Earnings in respect of pension costs and other post-retirement benefits is the contributions payable in the financial year. Differences between contributions payable in the financial year and contributions actually paid are included as either accruals or prepayments in the Balance Sheet.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Land and buildings 100 years straight line
Leasehold improvements 10 years straight line
Plant and machinery 6 years straight line
Vehicles 6 years straight line
Fixtures and fittings 6 years straight line
Computer equipment 6 years straight line
Leases

The Company as lessee
Assets held under finance leases, hire purchase contracts and other similar arrangements, which confer rights and obligations similar to those attached to owned assets, are capitalised as tangible fixed assets at the fair value of the leased asset (or, if lower, the present value of the minimum lease payments as determined at the inception of the lease) and are depreciated over the shorter of the lease terms and their useful lives. The capital elements of future lease obligations are recorded as liabilities, while the interest elements are charged to the Statement of Income and Retained Earnings over the period of the leases to produce a constant periodic rate of interest on the remaining balance of the liability.

Rentals under operating leases are charged on a straight-line basis over the lease term, even if the payments are not made on such a basis. Benefits received and receivable as an incentive to sign an operating lease are similarly spread on a straight-line basis over the lease term.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Provisions

Provisions are recognised when the Company has a present obligation (legal or constructive) as a result of a past event, it is probable that the Company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.

The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the Balance Sheet date, taking into account the risks and uncertainties surrounding the obligation. Where a provision is measured using the cash flows estimated to settle the present obligation, its carrying amount is the present value of those cash flows (when the effect of the time value of money is material).

When some or all of the economic benefits required to settle a provision are expected to be recovered from a third party, a receivable is recognised as an asset if it is virtually certain that reimbursement will be received and the amount of the receivable can be measured reliably.

2. Employees

2025 2024
Number Number
Monthly average number of persons employed by the Company during the year, including directors 50 48

3. Tangible assets

Land and buildings Leasehold improve-
ments
Plant and machinery Vehicles Fixtures and fittings Computer equipment Total
£ £ £ £ £ £ £
Cost
At 01 December 2024 5,493,943 664,783 1,883,555 45,190 2,355,986 284,230 10,727,687
Additions 0 0 102,799 115,269 1,172 4,012 223,252
At 30 November 2025 5,493,943 664,783 1,986,354 160,459 2,357,158 288,242 10,950,939
Accumulated depreciation
At 01 December 2024 626,602 102,931 973,594 32,638 1,333,660 216,244 3,285,669
Charge for the financial year 199,858 66,069 201,028 18,738 303,742 18,615 808,050
At 30 November 2025 826,460 169,000 1,174,622 51,376 1,637,402 234,859 4,093,719
Net book value
At 30 November 2025 4,667,483 495,783 811,732 109,083 719,756 53,383 6,857,220
At 30 November 2024 4,867,341 561,852 909,961 12,552 1,022,326 67,986 7,442,018
Leased assets included above:
Net book value
At 30 November 2025 0 0 148,307 104,062 0 0 252,369
At 30 November 2024 0 0 355,391 0 97,244 0 452,635

4. Debtors

2025 2024
£ £
Trade debtors 803,355 644,157
Prepayments 154,253 150,263
Corporation tax 66,575 0
Other debtors 11,250 11,250
1,035,433 805,670

5. Creditors: amounts falling due within one year

2025 2024
£ £
Bank loans (secured) 134,767 107,906
Trade creditors 534,405 720,563
Accruals and deferred income 446,318 384,683
Corporation tax 233,219 71,228
Other taxation and social security 75,618 54,881
Obligations under finance leases and hire purchase contracts 101,608 196,181
Other creditors 152,206 309,909
1,678,141 1,845,351

6. Creditors: amounts falling due after more than one year

2025 2024
£ £
Bank loans (secured) 3,294,973 3,477,616
Obligations under finance leases and hire purchase contracts 78,742 111,725
3,373,715 3,589,341

Amounts repayable after more than 5 years are included in creditors falling due over one year:

2025 2024
£ £
Bank loans (secured / repayable by instalments) 2,660,399 2,868,361

7. Called-up share capital

2025 2024
£ £
Allotted, called-up and fully-paid
34,755 Ordinary A shares of £ 1.00 each (2024: nil shares) 34,755 0
10,700 Ordinary B shares of £ 1.00 each (2024: nil shares) 10,700 0
10,700 Ordinary C shares of £ 1.00 each (2024: nil shares) 10,700 0
10,700 Ordinary D shares of £ 1.00 each (2024: nil shares) 10,700 0
Nil Ordinary shares (2024: 66,855 shares of £ 1.00 each) 0 66,855
66,855 66,855

8. Financial commitments

Commitments

Total future minimum lease payments under non-cancellable operating leases are as follows:

2025 2024
£ £
Within one year 85,000 85,000
Between one and five years 21,250 106,250
106,250 191,250

Pensions

The Company operates a defined contribution pension scheme for the directors and employees. The assets of the scheme are held separately from those of the Company in an independently administered fund.

2025 2024
£ £
Unpaid contributions due to the fund (included in "Other creditors") 7,391 7,049

9. Bank Loan

**Analysis of the maturity of loan is given below**

2025 2024
£ £
Amounts falling due within one year 134,767 107,906
Amount falling due 2-5 years 634,574 609,255
Amount falling due after 5 years 2,660,399 2,868,361
3,429,740 3,585,522

The Company has two bank loans totalling £3,429,740 (2024 - £3,585,522) which are secured by fixed charges over the Company's freehold property.